MEDP — Medpace Holdings Inc
NASDAQ · Healthcare · Diagnostics & Research
$586.22
+$3.01 (+0.52%)
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on NASDAQ. It is led by August James Troendle M.D., based in 5375 Medpace Way, Cincinnati, OH, United States, 45227, with about 5,900 employees. Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Latest reported MEDP revenue for 2025-09-30 was $659.9M. Net income was $111.1M. Revenue was up 9.4% from 2025-06-30 to 2025-09-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Use this MEDP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MEDP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MEDP SEC filings page. Lician reads the product cache first so this HTML stays unique to Medpace Holdings Inc even when a live quote feed is slow.
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
MEDP Key Statistics
Market Cap
$9.30B
Volume
245,765
Previous Close
$620.03
Day Range
$607.99 – $625.44
P/E Ratio
24.69
EPS
$12.63
Revenue
$2.11B
Net Income
$404.39M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+11.8%
Profit Margin
19.2%
Employees
5,900
MEDP Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $2.11B | $1.89B | $1.46B | $1.14B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $404.39M | $282.81M | $245.37M | $181.85M |
| EPS (Diluted) | $12.63 | $8.88 | $7.28 | $4.81 |
Total Assets
$2.10B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$669.44M
Operating Cash Flow
$608.82M
Free Cash Flow
$0.00
Medpace Holdings Inc Company Information
- Chairman & CEO
- August James Troendle M.D.
- Headquarters
- 5375 Medpace Way, Cincinnati, OH, United States, 45227
- Website
- www.medpace.com
- Phone
- (513) 579-9911
- IPO / Founded
- 2016-08-11
- Sector
- Healthcare
- Industry
- Diagnostics & Research